Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged 50 Years or Older

NCT01751165 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01751165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01751165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged 50 Years or Older
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
March 12, 2013
Completion date
April 8, 2015
Enrollment
354 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster